Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Dupont

Showing results (11-20 of 122) with videos related to

Pageof 13
Sort By:
International Journal of Cardiology|February 27, 2007
Myotomy through heart-port access for myocardial bridgingMatthias Dupont, Wilfried Mullens, Bernard De Bruyne, et al.
Acta Cardiologica|February 10, 2019
Contemporary choice of glucose lowering agents in heart failure patients with type 2 diabetesPieter Martens, Joyce Janssens, Jobbe Ramaekers, et al.
European Heart Journal. Acute Cardiovascular Care|October 26, 2021
Cardiac device troubleshooting in the intensive care unit: an educational reviewJeroen Dauw, Matthias Dupont, Pieter Martens, et al.
Cardiovascular Therapeutics|May 18, 2018
The reverse remodeling response to sacubitril/valsartan therapy in heart failure with reduced ejection fractionPieter Martens, Hanne Beliën, Matthias Dupont, et al.
The American Journal of Cardiology|May 24, 2017
Changes in Loop Diuretic Dose and Outcome After Cardiac Resynchronization Therapy in Patients With Heart Failure and Reduced Left Ventricular Ejection FractionsPieter Martens, Frederik H Verbrugge, Petra Nijst, et al.
Acta Cardiologica|November 27, 2018
Effects of sacubitril/valsartan on functional status and exercise capacity in real-world patientsChirik Wah Lau, Pieter Martens, Seppe Lambeets, et al.
Journal of Cardiac Failure|October 9, 2016
Mode of Death in Octogenarians Treated With Cardiac Resynchronization TherapyPieter Martens, Frederik H Verbrugge, Petra Nijst, et al.
Circulation. Heart Failure|August 18, 2012
Cystatin C identifies patients with stable chronic heart failure at increased risk for adverse cardiovascular eventsMatthias Dupont, Yuping Wu, Stanley L Hazen, et al.
Acta Cardiologica|June 19, 2018
Impact of sacubitril/valsartan on heart failure admissions: insights from real-world patient prescriptionsPieter Martens, Seppe Lambeets, Chirik Wah Lau, et al.
European Journal of Heart Failure|June 2, 2020
Digital health care solution for proactive heart failure management with the Cordella Heart Failure System: results of the SIRONA first-in-human studyWilfried Mullens, Faisal Sharif, Matthias Dupont, et al.
Pageof 13

Showing results (11-20 of 122) with videos related to

Sort By:
Pageof 13
International Journal of Cardiology|February 27, 2007
Myotomy through heart-port access for myocardial bridgingMatthias Dupont, Wilfried Mullens, Bernard De Bruyne, et al.
Acta Cardiologica|February 10, 2019
Contemporary choice of glucose lowering agents in heart failure patients with type 2 diabetesPieter Martens, Joyce Janssens, Jobbe Ramaekers, et al.
European Heart Journal. Acute Cardiovascular Care|October 26, 2021
Cardiac device troubleshooting in the intensive care unit: an educational reviewJeroen Dauw, Matthias Dupont, Pieter Martens, et al.
Cardiovascular Therapeutics|May 18, 2018
The reverse remodeling response to sacubitril/valsartan therapy in heart failure with reduced ejection fractionPieter Martens, Hanne Beliën, Matthias Dupont, et al.
The American Journal of Cardiology|May 24, 2017
Changes in Loop Diuretic Dose and Outcome After Cardiac Resynchronization Therapy in Patients With Heart Failure and Reduced Left Ventricular Ejection FractionsPieter Martens, Frederik H Verbrugge, Petra Nijst, et al.
Acta Cardiologica|November 27, 2018
Effects of sacubitril/valsartan on functional status and exercise capacity in real-world patientsChirik Wah Lau, Pieter Martens, Seppe Lambeets, et al.
Journal of Cardiac Failure|October 9, 2016
Mode of Death in Octogenarians Treated With Cardiac Resynchronization TherapyPieter Martens, Frederik H Verbrugge, Petra Nijst, et al.
Circulation. Heart Failure|August 18, 2012
Cystatin C identifies patients with stable chronic heart failure at increased risk for adverse cardiovascular eventsMatthias Dupont, Yuping Wu, Stanley L Hazen, et al.
Acta Cardiologica|June 19, 2018
Impact of sacubitril/valsartan on heart failure admissions: insights from real-world patient prescriptionsPieter Martens, Seppe Lambeets, Chirik Wah Lau, et al.
European Journal of Heart Failure|June 2, 2020
Digital health care solution for proactive heart failure management with the Cordella Heart Failure System: results of the SIRONA first-in-human studyWilfried Mullens, Faisal Sharif, Matthias Dupont, et al.
Pageof 13